What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate?

Bright Minds Biosciences Inc (NASDAQ:DRUG) is among the best psychedelic stocks to buy in 2026. The company has multiple psychedelic drug candidates, including potential medicines for epilepsy. Its flagship product candidate is BMB-101, which is being developed as a treatment for absence epilepsy.

What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate?

On March 5, H.C. Wainwright weighed on Bright Minds Biosciences Inc. (NASDAQ:DRUG) stock, raising the price target to $145 from $115 while reaffirming a Buy rating. This action followed H.C. Wainwright’s meeting with the company’s management and a review of Phase 2 study data for the lead product candidate BMB-101.

Bright Minds Biosciences is developing BMB-101 as a treatment for drug-resistant absence seizures as well as developmental and epileptic encephalopathies. In the Phase 2 trial, the compound met the primary efficacy endpoints for both targeted indications. That study was dubbed the BREAKTHROUGH trial, and its data was released in January.

After reviewing the Phase 2 trial data for BMB-101, H.C. Wainwright raised its probability of success for BMB-101 to 60% from 25%.

New York-headquartered Bright Minds Biosciences Inc (NASDAQ:DRUG) is a biotechnology company developing therapeutics for neuropsychiatric disorders. Its portfolio features multiple drug candidates, including BMB-101, a potential treatment for epileptic encephalopathies and absence epilepsies. Its other drug candidates include BMB-201, BMB-202, and BMB-105.

While we acknowledge the risk and potential of DRUG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than DRUG and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.